Rapid responses are electronic comments to the editor. They enable our users
to debate issues raised in articles published on bmj.com. A rapid response
is first posted online. If you need the URL (web address) of an individual
response, simply click on the response headline and copy the URL from the
browser window. A proportion of responses will, after editing, be published
online and in the print journal as letters, which are indexed in PubMed.
Rapid responses are not indexed in PubMed and they are not journal articles.
The BMJ reserves the right to remove responses which are being
wilfully misrepresented as published articles or when it is brought to our
attention that a response spreads misinformation.
From March 2022, the word limit for rapid responses will be 600 words not
including references and author details. We will no longer post responses
that exceed this limit.
The word limit for letters selected from posted responses remains 300 words.
Blood biomarkers have been invoked in acute stroke. Laskowitz et al
obtained results in 130 patients with focal signs and 41 patients with
ischemic stroke, and a prognostic panel with BNP, C reactive protein, D
-dimer, MMP-9 and S100B. A sensitivity of 81% and a specificity of 70%
for diagnosing ischemic stroke were recorded.
Delgado et al. examined the diagnostic value of a biomarkers panel to
differentiate ischemic stroke from cerebral hemorrhage. 776 patients with
stroke and 139 patients with ICH were tested for cRP, D-dimer, RAGE, MMP-9, S100B, BNp, neurothrophin-3, caspase -3, chimerin and secretagogin
with relative success differentiating ICH from IS.
Ref
Foerch C et al. Searching for oracles ?Blood biomarkers in acute stroke. Neurology 2009 ; 73: 393-399
Competing interests:
No competing interests
23 February 2011
Sabino Guillermo Echebarria Mendieta
MD neurologist.H San Eloy ( Barakaldo-Bizkaia)district clinics
C Reactive Protein and cardiovascular risk
Blood biomarkers have been invoked in acute stroke. Laskowitz et al
obtained results in 130 patients with focal signs and 41 patients with
ischemic stroke, and a prognostic panel with BNP, C reactive protein, D
-dimer, MMP-9 and S100B. A sensitivity of 81% and a specificity of 70%
for diagnosing ischemic stroke were recorded.
Delgado et al. examined the diagnostic value of a biomarkers panel to
differentiate ischemic stroke from cerebral hemorrhage. 776 patients with
stroke and 139 patients with ICH were tested for cRP, D-dimer, RAGE, MMP-9, S100B, BNp, neurothrophin-3, caspase -3, chimerin and secretagogin
with relative success differentiating ICH from IS.
Ref
Foerch C et al. Searching for oracles ?Blood biomarkers in acute stroke. Neurology 2009 ; 73: 393-399
Competing interests: No competing interests